These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14705191)

  • 1. Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach.
    Kossena GA; Charman WN; Boyd BJ; Dunstan DE; Porter CJ
    J Pharm Sci; 2004 Feb; 93(2):332-48. PubMed ID: 14705191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs.
    Kossena GA; Boyd BJ; Porter CJ; Charman WN
    J Pharm Sci; 2003 Mar; 92(3):634-48. PubMed ID: 12587125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug.
    Kossena GA; Charman WN; Boyd BJ; Porter CJ
    J Pharm Sci; 2005 Mar; 94(3):481-92. PubMed ID: 15619248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How relevant are assembled equilibrium samples in understanding structure formation during lipid digestion?
    Phan S; Salentinig S; Hawley A; Boyd BJ
    Eur J Pharm Biopharm; 2015 Oct; 96():117-24. PubMed ID: 26212786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug solubility in fatty acids as a formulation design approach for lipid-based formulations: a technical note.
    Lee YC; Dalton C; Regler B; Harris D
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1551-1556. PubMed ID: 29873584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-based formulations for oral administration of poorly water-soluble drugs.
    Mu H; Holm R; Müllertz A
    Int J Pharm; 2013 Aug; 453(1):215-24. PubMed ID: 23578826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro digestion testing of lipid-based delivery systems: calcium ions combine with fatty acids liberated from triglyceride rich lipid solutions to form soaps and reduce the solubilization capacity of colloidal digestion products.
    Devraj R; Williams HD; Warren DB; Mullertz A; Porter CJ; Pouton CW
    Int J Pharm; 2013 Jan; 441(1-2):323-33. PubMed ID: 23178598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: characterization, dissolution, in vitro digestion and incorporation into solid pellets.
    Abdalla A; Klein S; Mäder K
    Eur J Pharm Sci; 2008 Dec; 35(5):457-64. PubMed ID: 18940249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid determination of drug solubilization versus supersaturation in natural and digested lipids.
    Gautschi N; Bergström CA; Kuentz M
    Int J Pharm; 2016 Nov; 513(1-2):164-174. PubMed ID: 27609663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Models of the Gastrointestinal Environment. 2. Phase Behavior and Drug Solubilization Capacity of a Type I Lipid-Based Drug Formulation after Digestion.
    Birru WA; Warren DB; Han S; Benameur H; Porter CJ; Pouton CW; Chalmers DK
    Mol Pharm; 2017 Mar; 14(3):580-592. PubMed ID: 27936778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
    Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
    Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
    Alskär LC; Parrow A; Keemink J; Johansson P; Abrahamsson B; Bergström CAS
    J Control Release; 2019 Jun; 304():90-100. PubMed ID: 31047962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs.
    Yeap YY; Trevaskis NL; Porter CJ
    Mol Pharm; 2013 Jul; 10(7):2601-15. PubMed ID: 23697606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life.
    Arnold YE; Imanidis G; Kuentz M
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1262-9. PubMed ID: 22206451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the polymer partitioning method to probe the thermodynamic activity of poorly water-soluble drugs solubilized in model lipid digestion products.
    Boyd BJ; Porter CJ; Charman WN
    J Pharm Sci; 2003 Jun; 92(6):1262-71. PubMed ID: 12761815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of gastrointestinal absorption of poorly water soluble drugs via lipid based systems.
    Subramanian N; Ghosal SK
    Indian J Exp Biol; 2004 Nov; 42(11):1056-65. PubMed ID: 15587110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):844-55. PubMed ID: 20636872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
    Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
    Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation.
    Yeap YY; Trevaskis NL; Quach T; Tso P; Charman WN; Porter CJ
    Mol Pharm; 2013 May; 10(5):1874-89. PubMed ID: 23480483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward simplified oral lipid-based drug delivery using mono-/di-glycerides as single component excipients.
    Ilie AR; Griffin BT; Vertzoni M; Kuentz M; Cuyckens F; Wuyts K; Kolakovic R; Holm R
    Drug Dev Ind Pharm; 2020 Dec; 46(12):2051-2060. PubMed ID: 33124918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.